QC Organisms for performance qualification of culture media
Quanti-Cult Plus™ quality control micro-organisms are ideal for use in pharmaceutical applications such as growth promotion testing and method validation.
Quanti-Cult Plus provides quality control organisms in an easy-to-use format, saving time and money. Quanti-Cult Plus consists of preserved American Type Culture Collection (ATCC®) strains and predispensed rehydration fluid, ready to use in QC procedures. It comes complete with full instructions for use and certificate of analysis, so no need to down load or print any documents before starting work. Simply open the box and go.
Quanti-Cult Plus is stored in the fridge, so is always close by, and even when reconstituted is stable for up to 8 hours at 2-8 °C. A full validation report is available on request.
Unlike some other systems, Quanti-Cult Plus complies with the pharmacopoeia recommendation for viable micro-organisms used in inoculation to not exceed five passages from the original master seed-lot, so avoiding the potential for phenotypical inconsistencies.
Quanti-Cult Plus ensures conformance to pharmacopoeia requirements (EP/USP/JP); each set reproducibly delivering
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
